文献速递头颈外科

前颅底与中央颅底放射性骨坏死的表现及最佳管理:系统综述与Meta分析

Presentation and Optimal Management of Anterior and Central Skull Base Osteoradionecrosis: Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2024-10-15

该系统综述与Meta分析经PubMed、Embase和Cochrane Library检索,纳入13篇文章,比较保守药物治疗、手术清创及清创后血管化组织覆盖对前颅底与中央颅底放射性骨坏死的疗效。保守治疗197例中8例症状缓解(4.1%),手术治疗188例中135例缓解(71.8%),其中血管化组织组104例(91.2%)缓解。作者认为手术优于单纯药物治疗,血管化手术治疗优于单纯清创和(或)药物治疗。

要点

  • 保守治疗197例中8例症状缓解(4.1%),手术治疗188例中135例缓解(71.8%)。
  • 血管化组织组104例(91.2%)症状缓解。
  • 作者认为对颅底放射性骨坏死应更早考虑手术治疗,以防严重或致命后遗症。

核心结论

  • 手术在颅底放射性骨坏死缓解方面优于单纯药物治疗。
  • 血管化手术治疗与单纯手术清创和(或)药物治疗相比表现显著更好。
  • 作者认为对颅底放射性骨坏死患者应更早考虑手术治疗,以防严重或致命后遗症。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase和Cochrane Library,遵循PRISMA指南。
  • 共13篇文章符合纳入标准;患者按保守药物治疗与手术治疗分组。
  • 保守治疗包括高压氧治疗、抗生素、己酮可可碱-生育酚-氯膦酸盐或三者联合。

主要发现

  • 保守治疗组197例中8例症状缓解(4.1%)。
  • 手术治疗组188例中135例症状缓解(71.8%)。
  • 血管化组织组104例(91.2%)症状缓解。

关键数值与推荐

  • 保守治疗症状缓解8/197(4.1%)。
  • 手术治疗症状缓解135/188(71.8%)。
  • 血管化组织组症状缓解104例(91.2%)。

临床怎么用

  • 作者认为对颅底放射性骨坏死患者应更早考虑手术治疗,以防严重或致命后遗症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a systematic review and meta-analysis to compare the efficacy of conservative treatment versus surgical debridement versus debridement followed by vascularized tissue coverage to provide evidence-based guidance on the management of osteoradionecrosis of the anterior and central skull base. DATA SOURCES: PubMed, Embase, and Cochrane Library. REVIEW METHODS: Systematic review and data sources including PubMed, Embase, and Cochrane Library were accessed using PRISMA guidelines. Meta-analysis was performed on treatment type and resolution of osteoradionecrosis. RESULTS: A total of 13 articles met the inclusion criteria. Patients were categorized into conservative medical treatment versus surgical treatment. Conservative treatment included patients undergoing hyperbaric oxygen therapy, antibiotics, pentoxifylline-tocopherol-clodronate, or a combination of the three. Eight out of 197 patients treated with conservative therapy had resolution of symptoms (4.1%) while 135 of 188 patients treated with surgical intervention had resolution of symptoms (71.8%). Of these, 104 patients (91.2%) in the vascularized tissue group experienced resolution of symptoms. CONCLUSION: Surgery was superior to medical treatment alone in the resolution of skull base osteoradionecrosis. Vascularized surgical treatment fared significantly better when compared with both surgical debridement only and/or medical treatment. Our findings suggest that surgical treatment should be considered earlier in patients with skull base osteoradionecrosis to prevent severe or fatal sequelae. LEVEL OF EVIDENCE: NA Laryngoscope, 135:982-990, 2025.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Shah SR, Wu A, Sindwani R, et al. Presentation and Optimal Management of Anterior and Central Skull Base Osteoradionecrosis: Systematic Review and Meta-Analysis. Laryngoscope. 2024. PMID: 39404093. doi:10.1002/lary.31817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。